现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • NS 11394
NS 11394的可视化放大

NS 11394

A subunit-selective positive allosteric modulator of the GABAA receptor

原价
¥1037-4850
价格
830-3880
NS 11394的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajci6528
  • CAS: 951650-22-9
  • 别名: 3'-[5-(1-羟基-1-甲基乙基)-1H-苯并咪唑-1-基]-[1,1'-联苯]-2-甲腈
  • 分子式: C23H19N3O
  • 分子量: 353.42
  • 纯度: >98%
  • 溶解度: ≥ 35.3mg/mL in DMSO with gentle warming
  • 储存: Store at -20°C
  • 库存: 现货

Background

NS 11394 is a selective GABA(A) receptor-positive modulator.


Preclinical studies suggest that GABAA-1, 2, and 5-containing receptors can mediate the sedative/ motor-impairing, anxiolytic, and memory impairing effects, respectively.


In vitro: Previous study showed that NS11394 possessed a functional selectivity profile at GABA(A) receptors of alpha(5) > alpha(3) > alpha(2) > alpha(1) based on oocyte electrophysiology with human GABA(A) receptors. Moreover, compared with other subtype-selective ligands, NS11394 was unique in having superior efficacy for GABA(A)-alpha(3) receptors while maintaining low efficacy for GABA(A)-alpha(1) receptors [1].


In vivo: Animal study showed that NS11394 had an excellent PK profile, which correlated with pharmacodynamic endpoints of CNS receptor occupancy. In addition, it was showd that NS11394 was potent and highly effective in rodent anxiety models. The anxiolytic efficacy of NS11394 was most probably mediated via its high efficacy at GABA(A)-alpha(3) receptors, though the contribution of GABA(A)-alpha(2) receptors could not be excluded. Moreover, when compared with benzodiazepines, NS11394 had a significantly reduced side effect profile in rat and mouse, even at full CNS receptor occupancy. The authors attributed such benign side effect profile to very low efficacy of NS11394 at GABA(A)-alpha(1) receptors and a partial agonist profile of receptor subtypes. It was also found that NS11394 could impair memory in both rats and mice, which was possibly attributable to its efficacy at GABA(A)-alpha(5) receptors [1].


Clinical trial: Up to now, NS 11394 is still in the preclinical development stage.

Reference:
[1] Mirza NR, et al.? NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl- 2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J Pharmacol Exp Ther. 2008 Dec;327(3):954-68.

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服